| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
for Janus Kinase 2 Activation by Angiotensin II: Involvement of PYK2
Department of Biochemistry (G.D.F., S.S., T.I., S.E.), Vanderbilt University School of Medicine, Nashville, Tennessee 37232; Department of Anatomy and Physiology (E.D.M.), Meharry Medical College, Nashville, Tennessee 37208; Department of Biochemistry (T.S.), Sapporo Medical University, Sapporo 060-8556, Japan; and Institute of Molecular Oncology (M.O., T.K.), Showa University, Tokyo 142-8555, Japan
Address all correspondence and requests for reprints to: Satoru Eguchi, M.D., Ph.D., Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232. E-mail: satoru.eguchi{at}vanderbilt.edu
In vascular smooth muscle cells, angiotensin II (AngII) stimulates
association of its G protein-coupled AngII type 1 (AT1)
receptor with Janus kinase 2 (JAK2), resulting in the activation of
signal transducer and activator of transcription proteins. Although the
association and activation of subsequent signal transducer and
activator of transcription proteins appear to prerequire JAK2
activation, the signaling mechanism by which the AT1
receptor activates JAK2 remains uncertain. Here, we have examined the
signaling mechanism required for JAK2 activation by AngII in vascular
smooth muscle cells. We found that AngII, through the
AT1 receptor, rapidly stimulated JAK2 phosphorylation at
Tyr1007/1008, the critical sites for the kinase activation.
By using selective agonists and inhibitors, we demonstrated that PLC
and its derived signaling molecules, phosphatidylinositol
triphosphate/Ca2+ and diacylglycerol/PKC, were essential
for AngII-induced JAK2 phosphorylation. The PKC isoform required for
JAK2 activation appears to be PKC
since a selective PKC
but not
PKC
/ß inhibitor and dominant-negative PKC
overexpression
inhibited JAK2 activation. We further examined a link between JAK2 and
a Ca2+/PKC-sensitive tyrosine kinase, PYK2. We found
that PYK2 activation by AngII requires PKC
, and that PYK2 associates
with JAK2 constitutively. Moreover, transfection of two distinct PYK2
dominant-negative mutants markedly inhibited AngII-induced JAK2
activation. From these data we conclude that AT1-derived
signaling molecules, specifically Ca2+ and PKC
,
participate in AngII-induced JAK2 activation through PYK2. These data
provide a new mechanistic insight by which the hormone AngII exerts its
cytokine-like actions in mediating vascular remodeling.
This article has been cited by other articles:
![]() |
H. Ohtsu, S. Higuchi, H. Shirai, K. Eguchi, H. Suzuki, A. Hinoki, E. Brailoiu, A. D. Eckhart, G. D. Frank, and S. Eguchi Central Role of Gq in the Hypertrophic Signal Transduction of Angiotensin II in Vascular Smooth Muscle Cells Endocrinology, July 1, 2008; 149(7): 3569 - 3575. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Nakashima, G. D. Frank, H. Shirai, A. Hinoki, S. Higuchi, H. Ohtsu, K. Eguchi, A. Sanjay, M. E. Reyland, P. J. Dempsey, et al. Novel Role of Protein Kinase C-{delta} Tyr311 Phosphorylation in Vascular Smooth Muscle Cell Hypertrophy by Angiotensin II Hypertension, February 1, 2008; 51(2): 232 - 238. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. K. Mehta and K. K. Griendling Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system Am J Physiol Cell Physiol, January 1, 2007; 292(1): C82 - C97. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Hunyady and K. J. Catt Pleiotropic AT1 Receptor Signaling Pathways Mediating Physiological and Pathogenic Actions of Angiotensin II Mol. Endocrinol., May 1, 2006; 20(5): 953 - 970. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Liu, Y. Qiu, L. Xiao, and F. Dong Involvement of Protein Kinase C{epsilon} in the Negative Regulation of Akt Activation Stimulated by Granulocyte Colony-Stimulating Factor J. Immunol., February 15, 2006; 176(4): 2407 - 2413. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Woolfolk, S. Eguchi, H. Ohtsu, H. Nakashima, H. Ueno, W. T. Gerthoffer, and E. D. Motley Angiotensin II-induced activation of p21-activated kinase 1 requires Ca2+ and protein kinase C{delta} in vascular smooth muscle cells Am J Physiol Cell Physiol, November 1, 2005; 289(5): C1286 - C1294. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ohtsu, M. Mifune, G. D. Frank, S. Saito, T. Inagami, S. Kim-Mitsuyama, Y. Takuwa, T. Sasaki, J. D. Rothstein, H. Suzuki, et al. Signal-Crosstalk Between Rho/ROCK and c-Jun NH2-Terminal Kinase Mediates Migration of Vascular Smooth Muscle Cells Stimulated by Angiotensin II Arterioscler. Thromb. Vasc. Biol., September 1, 2005; 25(9): 1831 - 1836. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Skaletz-Rorowski, H. Eschert, J. Leng, B. Stallmeyer, J. R. Sindermann, E. Pulawski, and G. Breithardt PKC {delta}-induced activation of MAPK pathway is required for bFGF-stimulated proliferation of coronary smooth muscle cells Cardiovasc Res, July 1, 2005; 67(1): 142 - 150. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Talior, T. Tennenbaum, T. Kuroki, and H. Eldar-Finkelman PKC-{delta}-dependent activation of oxidative stress in adipocytes of obese and insulin-resistant mice: role for NADPH oxidase Am J Physiol Endocrinol Metab, February 1, 2005; 288(2): E405 - E411. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Wallace, D. VonDerLinden, K. He, S. J. Frank, and P. P. Sayeski Microarray analyses identify JAK2 tyrosine kinase as a key mediator of ligand-independent gene expression Am J Physiol Cell Physiol, October 1, 2004; 287(4): C981 - C991. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-S. Shi and J. H. Kehrl Pyk2 Amplifies Epidermal Growth Factor and c-Src-induced Stat3 Activation J. Biol. Chem., April 23, 2004; 279(17): 17224 - 17231. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Li, R. E. Feltzer, K. L. Dawson, E. A. Hudson, and B. J. Clark Janus Kinase 2 and Calcium Are Required for Angiotensin II-dependent Activation of Steroidogenic Acute Regulatory Protein Transcription in H295R Human Adrenocortical Cells J. Biol. Chem., December 26, 2003; 278(52): 52355 - 52362. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Talior, M. Yarkoni, N. Bashan, and H. Eldar-Finkelman Increased glucose uptake promotes oxidative stress and PKC-{delta} activation in adipocytes of obese, insulin-resistant mice Am J Physiol Endocrinol Metab, August 1, 2003; 285(2): E295 - E302. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. F. Loeser, C. B. Forsyth, A. M. Samarel, and H.-J. Im Fibronectin Fragment Activation of Proline-rich Tyrosine Kinase PYK2 Mediates Integrin Signals Regulating Collagenase-3 Expression by Human Chondrocytes through a Protein Kinase C-dependent Pathway J. Biol. Chem., June 27, 2003; 278(27): 24577 - 24585. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. Frank, M. Mifune, T. Inagami, M. Ohba, T. Sasaki, S. Higashiyama, P. J. Dempsey, and S. Eguchi Distinct Mechanisms of Receptor and Nonreceptor Tyrosine Kinase Activation by Reactive Oxygen Species in Vascular Smooth Muscle Cells: Role of Metalloprotease and Protein Kinase C-{delta} Mol. Cell. Biol., March 1, 2003; 23(5): 1581 - 1589. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. D. Motley, K. Eguchi, C. Gardner, A. L. Hicks, C. M. Reynolds, G. D. Frank, M. Mifune, M. Ohba, and S. Eguchi Insulin-Induced Akt Activation Is Inhibited by Angiotensin II in the Vasculature Through Protein Kinase C-{alpha} Hypertension, March 1, 2003; 41(3): 775 - 780. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Saito, G. D. Frank, M. Mifune, M. Ohba, H. Utsunomiya, E. D. Motley, T. Inagami, and S. Eguchi Ligand-independent trans-Activation of the Platelet-derived Growth Factor Receptor by Reactive Oxygen Species Requires Protein Kinase C-delta and c-Src J. Biol. Chem., November 15, 2002; 277(47): 44695 - 44700. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Lin, D. Wang, and W. Sadee Serum Response Factor Activation by Muscarinic Receptors via RhoA. NOVEL PATHWAY SPECIFIC TO M1 SUBTYPE INVOLVING CALMODULIN, CALCINEURIN, AND Pyk2 J. Biol. Chem., October 18, 2002; 277(43): 40789 - 40798. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |